Atacadão Toekomstige groei
Future criteriumcontroles 3/6
Atacadão zal naar verwachting groeien in winst en omzet met respectievelijk 56.3% en 6% per jaar. De winst per aandeel zal naar verwachting groeien met 55.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.8% zijn.
Belangrijke informatie
56.3%
Groei van de winst
55.4%
Groei van de winst per aandeel
| Consumer Retailing winstgroei | 29.8% |
| Inkomstengroei | 6.0% |
| Toekomstig rendement op eigen vermogen | 9.8% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 25 Nov 2024 |
Recente toekomstige groei-updates
Analyst Estimates: Here's What Brokers Think Of Atacadão S.A. (BVMF:CRFB3) After Its Third-Quarter Report
Nov 03
Atacadão S.A. Just Missed EPS By 59%: Here's What Analysts Think Will Happen Next
May 09Atacadão S.A. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Feb 22Recent updates
Atacadão's (BVMF:CRFB3) Soft Earnings Are Actually Better Than They Appear
Nov 08Analyst Estimates: Here's What Brokers Think Of Atacadão S.A. (BVMF:CRFB3) After Its Third-Quarter Report
Nov 03Atacadão S.A.'s (BVMF:CRFB3) Share Price Could Signal Some Risk
Oct 02Here's Why Atacadão (BVMF:CRFB3) Is Weighed Down By Its Debt Load
Jul 19Atacadão S.A.'s (BVMF:CRFB3) Popularity With Investors Is Under Threat From Overpricing
Jun 13Atacadão S.A. Just Missed EPS By 59%: Here's What Analysts Think Will Happen Next
May 09Does Atacadão (BVMF:CRFB3) Have A Healthy Balance Sheet?
Mar 28Atacadão S.A. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Feb 22Atacadão S.A.'s (BVMF:CRFB3) Share Price Could Signal Some Risk
Feb 05These 4 Measures Indicate That Atacadão (BVMF:CRFB3) Is Using Debt In A Risky Way
Nov 17Atacadão (BVMF:CRFB3) Seems To Be Using A Lot Of Debt
Aug 16Atacadão (BVMF:CRFB3) Has A Somewhat Strained Balance Sheet
May 05We Think Atacadão (BVMF:CRFB3) Is Taking Some Risk With Its Debt
Jan 16We Think Atacadão (BVMF:CRFB3) Is Taking Some Risk With Its Debt
Oct 12Atacadão (BVMF:CRFB3) Has A Somewhat Strained Balance Sheet
Jul 14Atacadão's (BVMF:CRFB3) Returns On Capital Not Reflecting Well On The Business
May 18Here's What To Make Of Atacadão's (BVMF:CRFB3) Decelerating Rates Of Return
Feb 14These 4 Measures Indicate That Atacadão (BVMF:CRFB3) Is Using Debt Extensively
Dec 29Returns At Atacadão (BVMF:CRFB3) Appear To Be Weighed Down
Nov 16Atacadão (BVMF:CRFB3) Takes On Some Risk With Its Use Of Debt
Sep 30Atacadão (BVMF:CRFB3) Has More To Do To Multiply In Value Going Forward
Aug 18Is Atacadão (BVMF:CRFB3) A Risky Investment?
Jul 02Atacadão (BVMF:CRFB3) Has Some Way To Go To Become A Multi-Bagger
May 20Should You Or Shouldn't You: A Dividend Analysis on Atacadão S.A. (BVMF:CRFB3)
Apr 29Atacadão (BVMF:CRFB3) Seems To Use Debt Quite Sensibly
Mar 16Atacadão S.A.'s (BVMF:CRFB3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 23Is Atacadão (BVMF:CRFB3) Likely To Turn Things Around?
Feb 05
Atacadão S.A. (BVMF:CRFB3) Is Yielding 1.2% - But Is It A Buy?
Jan 18Introducing Atacadão (BVMF:CRFB3), A Stock That Climbed 26% In The Last Three Years
Dec 31Is Atacadão (BVMF:CRFB3) A Risky Investment?
Dec 11Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 130,876 | 2,229 | 2,753 | 6,257 | 13 |
| 12/31/2025 | 122,398 | 1,647 | 2,371 | 5,467 | 14 |
| 12/31/2024 | 115,409 | 990 | 2,819 | 4,595 | 7 |
| 9/30/2024 | 113,953 | 25 | 2,160 | 4,657 | N/A |
| 6/30/2024 | 112,570 | -64 | 2,685 | 5,481 | N/A |
| 3/31/2024 | 110,417 | -643 | 2,772 | 5,709 | N/A |
| 12/31/2023 | 109,859 | -795 | 1,198 | 4,729 | N/A |
| 9/30/2023 | 110,097 | 196 | 2,411 | 6,654 | N/A |
| 6/30/2023 | 110,855 | 387 | 970 | 5,050 | N/A |
| 3/31/2023 | 108,668 | 1,256 | 307 | 4,405 | N/A |
| 12/31/2022 | 102,890 | 1,739 | 3,459 | 6,973 | N/A |
| 9/30/2022 | 94,902 | 2,330 | 2,059 | 4,820 | N/A |
| 6/30/2022 | 87,014 | 2,645 | 3,594 | 6,047 | N/A |
| 3/31/2022 | 80,454 | 2,591 | 2,300 | 4,897 | N/A |
| 12/31/2021 | 77,751 | 3,144 | 1,766 | 4,444 | N/A |
| 9/30/2021 | 76,686 | 3,062 | -1,768 | 2,477 | N/A |
| 6/30/2021 | 75,048 | 3,111 | -1,738 | 2,120 | N/A |
| 3/31/2021 | 73,122 | 3,231 | -1,316 | 2,143 | N/A |
| 12/31/2020 | 71,191 | 2,671 | 669 | 4,033 | N/A |
| 9/30/2020 | 67,403 | 2,372 | 478 | 2,283 | N/A |
| 6/30/2020 | 63,868 | 2,115 | 1,092 | 3,004 | N/A |
| 3/31/2020 | 61,803 | 935 | 159 | 2,201 | N/A |
| 12/31/2019 | 60,064 | 1,013 | 853 | 2,665 | N/A |
| 9/30/2019 | 58,231 | 1,013 | -27 | 1,853 | N/A |
| 6/30/2019 | 57,033 | 938 | 284 | 2,195 | N/A |
| 3/31/2019 | 55,365 | 1,821 | 43 | 1,877 | N/A |
| 12/31/2018 | 54,267 | 1,660 | 1,368 | 3,100 | N/A |
| 9/30/2018 | 52,806 | 1,621 | 737 | 2,398 | N/A |
| 6/30/2018 | 51,707 | 1,828 | N/A | 1,910 | N/A |
| 3/31/2018 | 50,946 | 1,718 | N/A | 2,435 | N/A |
| 12/31/2017 | 50,280 | 1,599 | N/A | 2,887 | N/A |
| 9/30/2017 | 49,728 | 1,537 | N/A | 2,541 | N/A |
| 6/30/2017 | 49,238 | 1,224 | N/A | 2,794 | N/A |
| 3/31/2017 | 48,335 | 1,199 | N/A | 2,159 | N/A |
| 12/31/2016 | 47,534 | 1,174 | N/A | 2,957 | N/A |
| 12/31/2015 | 41,538 | 766 | N/A | 1,736 | N/A |
| 12/31/2014 | 36,751 | 708 | N/A | 735 | N/A |
| 12/31/2013 | 17,082 | 461 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei CRFB3 ( 56.3% per jaar) ligt boven de spaarquote ( 10.4% ).
Winst versus markt: De winst van CRFB3 ( 56.3% per jaar) zal naar verwachting sneller groeien dan de BR markt ( 12.6% per jaar).
Hoge groeiwinsten: De winst van CRFB3 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van CRFB3 ( 6% per jaar) zal naar verwachting langzamer groeien dan de markt BR ( 7.4% per jaar).
Hoge groei-inkomsten: De omzet van CRFB3 ( 6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CRFB3 zal naar verwachting over 3 jaar laag zijn ( 9.8 %).